Patents by Inventor Ellen Foxman

Ellen Foxman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250067739
    Abstract: In one aspect, the invention provides a method for detecting a viral-only or a bacterial-associated respiratory infection in a patient, the method comprising analyzing a respiratory sample to determine levels of at least two respiratory virus infection-associated molecules, at least two bacterial respiratory infection-associated molecules, and comparing the levels of the respiratory virus infection-associated molecules and/or the levels of the bacterial respiratory infection-associated molecules with a predetermined reference level.
    Type: Application
    Filed: December 22, 2022
    Publication date: February 27, 2025
    Applicant: Yale University
    Inventor: Ellen Foxman
  • Patent number: 12110564
    Abstract: In one aspect the invention provides a method for distinguishing between a viral-only infection of the upper respiratory tract or a bacterial or viral/bacterial coinfection in a patient by analyzing a respiratory sample.
    Type: Grant
    Filed: May 6, 2019
    Date of Patent: October 8, 2024
    Assignee: Yale University
    Inventor: Ellen Foxman
  • Patent number: 11965218
    Abstract: The present disclosure concerns methods of detecting viral respiratory infections by analyzing biomarkers in a viral transport medium sample. In various embodiments the biomarkers are assessed by measuring mRNA or protein. In certain embodiments the biomarkers are nasal-virus induced molecules.
    Type: Grant
    Filed: October 11, 2017
    Date of Patent: April 23, 2024
    Assignee: YALE UNIVERSITY
    Inventors: Ellen Foxman, Marie Landry
  • Publication number: 20230203602
    Abstract: The present disclosure concerns methods of detecting viral respiratory infections by analyzing biomarkers in a viral transport medium sample. In various embodiments the biomarkers are assessed by measuring mRNA or protein. In certain embodiments the biomarkers are nasal-virus induced molecules.
    Type: Application
    Filed: October 11, 2017
    Publication date: June 29, 2023
    Inventors: Ellen FOXMAN, Marie LANDRY
  • Publication number: 20210363601
    Abstract: In one aspect the invention provides a method for distinguishing between a viral-only infection of the upper respiratory tract or a bacterial or viral/bacterial coinfection in a patient by analyzing a respiratory sample.
    Type: Application
    Filed: May 6, 2019
    Publication date: November 25, 2021
    Inventor: Ellen Foxman